Vaccine Contract Manufacturing Market Share, Sourcing Strategy and Downstream Buyers 2020-2025
27th Aug 2020 - Global Vaccine Contract Manufacturing Market size is expected to reach USD 4.0 billion by 2025, A vaccine provides active acquired immunity to a disease. The demand for vaccine contract manufacturing is increasing in the market. Vaccine manufacturing is a complex process, in which effectivity, safety and consistency are the most important part for the manufacturers. It offers many services such as production process, cell line development, construction & operation of manufacturing product, process optimization, fermentation and analytical characterization, which fuels the market growth in the coming years. The vaccine contract manufacturing market registering a CAGR of 9.3% in the upcoming period as the scope, product types, and its applications are increasing across the globe.
Vaccine contract
services offer cost-saving benefits to their clients. Also, they help to save
time in operations & management of a research and production facility. The
growing demand for vaccine development from the private sector as well as
governments in developing and industrialized countries is expected to witness
significant growth of the market in the coming years.
Access Vaccine Contract
Manufacturing Market Report with TOC @ https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market
In the market, various
types of vaccines are available such as inactivated vaccines, attenuated vaccines,
toxoid-based vaccines, subunit-based vaccines, DNA-based vaccines, recombinant
vector vaccines, synthetic vaccines and others. The “attenuated vaccines” is
expected to hold the large market share in the upcoming period due to their
ability to elicit strong and antibody responses. These vaccines offer lifetime
immunities with just one or two doses. Moreover, proper handling conditions,
especially with respect to storage and maintenance will continue to drive the
segment in the coming years.
In addition, in the
market some single as well as combination vaccine are available. The single
vaccine such as influenza virus, ebola virus, chickenpox, smallpox, polio,
tetanus, tuberculosis and others could be explored in vaccine contract
manufacturing industry. The factors that play an important role in the growth
of market include increasing demand, growing population, increasing
urbanization & industrialization, growing pharmaceutical industry, increase
in the number of countries demanding the introduction of vaccines, stringent
government rules & regulations and increasing awareness about vaccination
& its benefits in developing countries. Moreover, increasing prevalence of
various bacterial and viral infections is a main factor drive the growth of the
vaccine contract manufacturing market in the next couple of years.
However, high cost of
vaccination, regulatory challenges and patent expiration in recent times are
negatively impacting the growth of vaccine contract manufacturing industry. The
market is widely analyzed based on different regional factors such as gross
domestic product (GDP), demographics, acceptance, inflation rate and others.
The market is categorized based on vaccine type, product type, workflow,
application and geography.
The market is classified
into workflow such as downstream and upstream. The “downstream” segment is
further segregated into fill & finish operations, packaging and analytical
& QC studies whereas the segment “upstream” is segmented into mammalian
expression systems, yeast expression systems, bacterial expression systems,
baculovirus/insect expression systems and others. Vaccine production requires
skilled personnel for downstream as well as upstream processing. The
“downstream” segment is expected to witness significant growth in the coming
years owing to the robust demand for downstream processing and sophisticated
equipment for efficient product recovery.
The key players contributing to the robust development of the vaccine contract manufacturing market include Lonza, Paragon Bioservices Inc., Ajinomoto Althea Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Merck KGaA, Cytovance Biologics, Catalent Inc., IDT Biologika GmbH, Albany Molecular Research Inc., PRA Health Sciences, ICON plc., Pharmaceutical Product Development, LLC, and Cobra Bio. The major market players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Request a Sample Copy
of Vaccine Contract Manufacturing Market Report @ https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market/request-sample
Vaccine Contract Manufacturing Regional Outlook (Revenue, USD Million, 2014
- 2025)
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• Asia Pacific
• India
• China
• Latin America
• Brazil
• Middle East & Africa
• South Africa
Comments
Post a Comment